Pub Date : 1900-01-01DOI: 10.25179/tjem.2021-84564
Başak ÖZGEN SAYDAM, S. C. Adiyaman, Berfu Yeşi̇lli̇, A. Bektaş, Özgül Vatansever, Nalan Aydin, Simge Ruhiye Yilmaz Kavcar, Canan Deği̇rmenci̇, F. Bayraktar, B. Akıncı
Objective: Simultaneous teamwork is an advanced collaboration subtype that includes the patient’s evaluation by the team members (including physician, nurse and dietician) together in the same session. Our study aimed to investigate the effect of a simultaneous teamwork approach on metabolic and clinical outcomes of patients with Type 1 diabetes using an insulin pump. Material and Methods: This retrospective study included 49 previous insulin pump users with Type 1 diabetes who participated in a simultaneous teamwork protocol. Metabolic and clinical parameters were collected before and after the teamwork approach. A separate analysis of 16 patients in whom insulin pump was initiated with simultaneous teamwork and pregnancy data from 9 patients were also reported. Results: Simultaneous teamwork resulted in a significant reduction in the frequency of hypoglycemic episodes in previous insulin pump users with Type 1 diabetes. Hemoglobin A1c decreased, but the difference was statistically insignificant. Simultaneous teamwork was also efficient on patients initiated an insulin pump and for pregnancy follow-up in 2 separate subsets of patients with Type 1 diabetes. Conclusion: The simultaneous teamwork approach is a practical method to manage Type 1 diabetes in insulin pump users with the potential to reduce the frequency of hypoglycemic episodes.
{"title":"Simultaneous Teamwork May Improve Hypoglycemia Rates in Patients with Type 1 Diabetes Using an Insulin Pump","authors":"Başak ÖZGEN SAYDAM, S. C. Adiyaman, Berfu Yeşi̇lli̇, A. Bektaş, Özgül Vatansever, Nalan Aydin, Simge Ruhiye Yilmaz Kavcar, Canan Deği̇rmenci̇, F. Bayraktar, B. Akıncı","doi":"10.25179/tjem.2021-84564","DOIUrl":"https://doi.org/10.25179/tjem.2021-84564","url":null,"abstract":"Objective: Simultaneous teamwork is an advanced collaboration subtype that includes the patient’s evaluation by the team members (including physician, nurse and dietician) together in the same session. Our study aimed to investigate the effect of a simultaneous teamwork approach on metabolic and clinical outcomes of patients with Type 1 diabetes using an insulin pump. Material and Methods: This retrospective study included 49 previous insulin pump users with Type 1 diabetes who participated in a simultaneous teamwork protocol. Metabolic and clinical parameters were collected before and after the teamwork approach. A separate analysis of 16 patients in whom insulin pump was initiated with simultaneous teamwork and pregnancy data from 9 patients were also reported. Results: Simultaneous teamwork resulted in a significant reduction in the frequency of hypoglycemic episodes in previous insulin pump users with Type 1 diabetes. Hemoglobin A1c decreased, but the difference was statistically insignificant. Simultaneous teamwork was also efficient on patients initiated an insulin pump and for pregnancy follow-up in 2 separate subsets of patients with Type 1 diabetes. Conclusion: The simultaneous teamwork approach is a practical method to manage Type 1 diabetes in insulin pump users with the potential to reduce the frequency of hypoglycemic episodes.","PeriodicalId":425605,"journal":{"name":"The Turkish Journal of Endocrinology and Metabolism","volume":"48 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131743598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.25179/tjem.2017-56498
E. Faraji, Sepideh Tahsini Tekantapeh
{"title":"Overlapping Between Thymus Neuroendocrine Carcinoma as an Ectopic Cushing Syndrome and Exogenous Cushing’s Syndrome: A Case Report","authors":"E. Faraji, Sepideh Tahsini Tekantapeh","doi":"10.25179/tjem.2017-56498","DOIUrl":"https://doi.org/10.25179/tjem.2017-56498","url":null,"abstract":"","PeriodicalId":425605,"journal":{"name":"The Turkish Journal of Endocrinology and Metabolism","volume":"85 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114208563","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.25179/tjem.2018-62921
Ceyla Konca Değertekin, Ö. Turhan İyidir, D. Gogas Yavuz
{"title":"A Bibliometric Analysis of Turkey’s Contribution to Bone Health Literature from an Endocrinologist Perspective","authors":"Ceyla Konca Değertekin, Ö. Turhan İyidir, D. Gogas Yavuz","doi":"10.25179/tjem.2018-62921","DOIUrl":"https://doi.org/10.25179/tjem.2018-62921","url":null,"abstract":"","PeriodicalId":425605,"journal":{"name":"The Turkish Journal of Endocrinology and Metabolism","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126134715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.25179/TJEM.2018-63449
M. Keskin, O. Tekin, A. Koca, M. Dağdeviren, G. Şimşek, M. Altay, D. Ertuğrul
{"title":"Case Report: Fixed Drug Eruption Caused by Dapagliflozin","authors":"M. Keskin, O. Tekin, A. Koca, M. Dağdeviren, G. Şimşek, M. Altay, D. Ertuğrul","doi":"10.25179/TJEM.2018-63449","DOIUrl":"https://doi.org/10.25179/TJEM.2018-63449","url":null,"abstract":"","PeriodicalId":425605,"journal":{"name":"The Turkish Journal of Endocrinology and Metabolism","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114869167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.25179/tjem.2021-84035
V. B. Turhan, A. Ünsal
Objective: To identify and analyze the 100 most cited articles on thyroid cancer since 1975, thus, allowing their easy access for researchers in this field. Material and Methods: This study is a bibliometric analysis of research publications acquired from the Web of Science database. We evaluated the first 100 articles receiving the most citations in the field of thyroid cancer since 1975. Then, all research publications were compiled using journal information into different categories based on the study type, country, research centers, authors, and publication dates. All data were reported as percentages, numbers, and graphs. Results: In this study, we listed 8,608 full-length English-language articles. Our findings showed that the most cited article received 4,325 citations to date, while the Journal of Clinical Endocrinology Metabolism, a Thyroid journal, received the most number of citations (n:6531), publishing seventeen of the articles from our study. Also, thirty-two articles were from the field of oncology. The country with the most number of publications was the United States of America (n=70) in the years 2005, 2008, and 2009 (n=8). Conclusion: It is essential to acknowledge the top-cited articles in thyroid cancer since they contain essential information, research, and advances in its treatment. Our analysis of the first 100 articles included the most important papers with the most significant impact on thyroid cancer research. In our list, we acknowledged the most productive authors and institutions along with their research articles.
目的:对1975年以来被引次数最多的100篇关于甲状腺癌的文章进行识别和分析，为该领域的研究人员提供参考。材料和方法:本研究是对从Web of Science数据库获得的研究出版物进行文献计量学分析。我们评估了1975年以来在甲状腺癌领域中被引用最多的前100篇文章。然后，根据研究类型、国家、研究中心、作者和出版日期，利用期刊信息对所有研究出版物进行分类。所有数据均以百分比、数字和图表形式报告。结果:在本研究中，我们列出了8608篇完整的英文文章。我们的研究结果显示，迄今为止，被引用次数最多的文章被引用了4,325次，而被引用次数最多的是甲状腺杂志Journal of Clinical Endocrinology Metabolism (n:6531)，发表了17篇来自我们研究的文章。此外，32篇文章来自肿瘤学领域。2005年、2008年和2009年发表论文最多的国家是美国(n=70) (n=8)。结论:了解被引用次数最多的甲状腺癌相关文章是必要的，因为它们包含了甲状腺癌治疗的基本信息、研究和进展。我们对前100篇文章的分析包括了对甲状腺癌研究影响最大的最重要的论文。在我们的榜单中，我们认可了最具生产力的作者和机构以及他们的研究文章。
{"title":"Top 100 Cited Articles in Thyroid Cancer: A Bibliometric Analysis","authors":"V. B. Turhan, A. Ünsal","doi":"10.25179/tjem.2021-84035","DOIUrl":"https://doi.org/10.25179/tjem.2021-84035","url":null,"abstract":"Objective: To identify and analyze the 100 most cited articles on thyroid cancer since 1975, thus, allowing their easy access for researchers in this field. Material and Methods: This study is a bibliometric analysis of research publications acquired from the Web of Science database. We evaluated the first 100 articles receiving the most citations in the field of thyroid cancer since 1975. Then, all research publications were compiled using journal information into different categories based on the study type, country, research centers, authors, and publication dates. All data were reported as percentages, numbers, and graphs. Results: In this study, we listed 8,608 full-length English-language articles. Our findings showed that the most cited article received 4,325 citations to date, while the Journal of Clinical Endocrinology Metabolism, a Thyroid journal, received the most number of citations (n:6531), publishing seventeen of the articles from our study. Also, thirty-two articles were from the field of oncology. The country with the most number of publications was the United States of America (n=70) in the years 2005, 2008, and 2009 (n=8). Conclusion: It is essential to acknowledge the top-cited articles in thyroid cancer since they contain essential information, research, and advances in its treatment. Our analysis of the first 100 articles included the most important papers with the most significant impact on thyroid cancer research. In our list, we acknowledged the most productive authors and institutions along with their research articles.","PeriodicalId":425605,"journal":{"name":"The Turkish Journal of Endocrinology and Metabolism","volume":"20 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117050722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.25179/TJEM.2018-63502
Bushra Mubarak, S. Ashraf, Raheela Aslam
®Copyright 2019 by Turkish Journal of Endocrinology and Metabolism Association Turkish Journal of Endocrinology and Metabolism published by Türkiye Klinikleri Determination of Serum Thyroid Hormones and Electrolytes in Hypothyroid and Hyperthyroid Females-A Case Control Study in Lahore, Pakistan Hipotiroid ve Hipertiroid Kadınlarda Serum Tiroid Hormonları ve Elektrolitlerinin Belirlenmesi-Lahor, Pakistan'da Bir Vaka Kontrol Çalışması
{"title":"Determination of Serum Thyroid Hormones and Electrolytes in Hypothyroid and Hyperthyroid Females-A Case Control Study in Lahore, Pakistan","authors":"Bushra Mubarak, S. Ashraf, Raheela Aslam","doi":"10.25179/TJEM.2018-63502","DOIUrl":"https://doi.org/10.25179/TJEM.2018-63502","url":null,"abstract":"®Copyright 2019 by Turkish Journal of Endocrinology and Metabolism Association Turkish Journal of Endocrinology and Metabolism published by Türkiye Klinikleri Determination of Serum Thyroid Hormones and Electrolytes in Hypothyroid and Hyperthyroid Females-A Case Control Study in Lahore, Pakistan Hipotiroid ve Hipertiroid Kadınlarda Serum Tiroid Hormonları ve Elektrolitlerinin Belirlenmesi-Lahor, Pakistan'da Bir Vaka Kontrol Çalışması","PeriodicalId":425605,"journal":{"name":"The Turkish Journal of Endocrinology and Metabolism","volume":"52 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122988901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.25179/tjem.2019-65793
D. Vurallı
{"title":"Growth Hormone Deficiency in the Transition Period","authors":"D. Vurallı","doi":"10.25179/tjem.2019-65793","DOIUrl":"https://doi.org/10.25179/tjem.2019-65793","url":null,"abstract":"","PeriodicalId":425605,"journal":{"name":"The Turkish Journal of Endocrinology and Metabolism","volume":"85 1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115842520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.25179/tjem.2021-83643
Emine Kartal Baykan
Anti-insulin antibody syndrome is a rare autoimmune disorder that is characterized by severe hypoglycemia, elevated blood insulin level, insulin autoantibodies, and the absence of pancreas islet cell pathology or exogenous insulin exposure. Alpha-lipoic acid is a sulfhydrylcontaining compound that is used to treat diabetic peripheral neuropathy and was first reported as a cause of anti-insulin antibody syndrome in Japan in 2003. In the literature, 17 cases with anti-insulin antibody syndrome following alpha-lipoic acid use have been reported from Japan, along with one case from Turkey, two from Korea, and seven cases from Italy. In this article, we present three cases with anti-insulin antibody syndrome developed after alpha-lipoic acid use. Case 1: A 72-year-old male patient was observed to have lost consciousness at home. This patient had no history of diabetes mellitus, diabetic medication, or insulin use. The patient complained of tiredness, palpitations, and sweating that began 3-4 h after eating but regressed after eating during the past month. The patient had a history of diagnosis with lumbar disk hernia two months ago and was using alpha-lipoic acid (600 mg). Case 2: A 67-year-old diabetic female patient using alpha-lipoic acid (600 mg) following the diagnosis of diabetic peripheral neuropathy. She complained of shivering and sweating two to three hours after a meal that started after starting alpha-lipoic acid therapy. Case 3: A 46-year-old male patient complained of fatigue, palpitations, and sweating for the last three weeks. Seven weeks ago, he started using alpha-lipoic acid (600 mg) after being diagnosed with carpal tunnel syndrome. The patients were diagnosed with anti-insulin antibody syndrome secondary to alpha-lipoic acid use, following which their alpha-lipoic therapy was discontinued. Alpha-lipoic acid is widely used in the treatment of diabetic peripheral neuropathy, nutritional support, or as an anti-aging agent. However, it should be noted that its use may cause anti-insulin antibody syndrome in genetically predisposed people.
{"title":"Anti-Insulin Antibody Syndrome Following Alpha-Lipoic Acid Use in Turkish Patients: Report of Three New Cases","authors":"Emine Kartal Baykan","doi":"10.25179/tjem.2021-83643","DOIUrl":"https://doi.org/10.25179/tjem.2021-83643","url":null,"abstract":"Anti-insulin antibody syndrome is a rare autoimmune disorder that is characterized by severe hypoglycemia, elevated blood insulin level, insulin autoantibodies, and the absence of pancreas islet cell pathology or exogenous insulin exposure. Alpha-lipoic acid is a sulfhydrylcontaining compound that is used to treat diabetic peripheral neuropathy and was first reported as a cause of anti-insulin antibody syndrome in Japan in 2003. In the literature, 17 cases with anti-insulin antibody syndrome following alpha-lipoic acid use have been reported from Japan, along with one case from Turkey, two from Korea, and seven cases from Italy. In this article, we present three cases with anti-insulin antibody syndrome developed after alpha-lipoic acid use. Case 1: A 72-year-old male patient was observed to have lost consciousness at home. This patient had no history of diabetes mellitus, diabetic medication, or insulin use. The patient complained of tiredness, palpitations, and sweating that began 3-4 h after eating but regressed after eating during the past month. The patient had a history of diagnosis with lumbar disk hernia two months ago and was using alpha-lipoic acid (600 mg). Case 2: A 67-year-old diabetic female patient using alpha-lipoic acid (600 mg) following the diagnosis of diabetic peripheral neuropathy. She complained of shivering and sweating two to three hours after a meal that started after starting alpha-lipoic acid therapy. Case 3: A 46-year-old male patient complained of fatigue, palpitations, and sweating for the last three weeks. Seven weeks ago, he started using alpha-lipoic acid (600 mg) after being diagnosed with carpal tunnel syndrome. The patients were diagnosed with anti-insulin antibody syndrome secondary to alpha-lipoic acid use, following which their alpha-lipoic therapy was discontinued. Alpha-lipoic acid is widely used in the treatment of diabetic peripheral neuropathy, nutritional support, or as an anti-aging agent. However, it should be noted that its use may cause anti-insulin antibody syndrome in genetically predisposed people.","PeriodicalId":425605,"journal":{"name":"The Turkish Journal of Endocrinology and Metabolism","volume":"196 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116982837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.25179/tjem.2019-66342
F. Saraç, S. Savaş, Bahattin Gökdemir, F. Akçiçek
D O I: 10 .2 51 79 /t je m .2 01 966 34 2 Objective: The aim of the present study was to determine the lipid profile in the elderly and middle-aged patients with Type 2 diabetes mellitus (DM) and its relation with gender. Material and Methods: A total of 592 patients with Type 2 DM aged ≥60 years and 269 diabetic patients aged <60 years as middle-aged with initial admissions or patients with two months of antihyperlipidemic medicine pause were recruited from the internal medicine outpatient clinic during December 2012-March 2018. Demographic and biochemical data were collected retrospectively. Abnormal lipid levels were accepted as total-cholesterol >200 mg/dL, low density lipoprotein-cholesterol (LDL-C) ≥100 mg/dL, triglyceride (TG) ≥150 mg/dL, and high density lipoproteincholesterol (HDL-C) <50 in women <40 mg/dL in men. Results: In total, 506 (85.4%) elderly and 248 (92.1%) middle-aged patients had one or more types of dyslipidemia. There were statistically significant differences in the frequencies of isolated high TG (x2=7.54, p=0.01) and combined two parameter dyslipidemia such as LDL-C ≥100 mg/dL & HDL-C <40 mg/dL & TG <150 mg/dL (x2=4.30, p=0.03) for men between elderly and middle-aged patients. Combined two-parameter dyslipidemia such as LDL-C ≥100 mg/dL, TG ≥150 mg/dL & HDL-C >50 mg/dL (x2=6.64, p=0.01), and isolated low HDL-C (x2=2.91, p=0.05) for women were found to be different between the elderly and middle-aged patients. Conclusion: Hypertriglyceridemia with high LDL-C and isolated low HDL-C were more common in the elderly women than that in middle-aged women where isolated hypertriglyceridemia and combined high LDL-C with low HDL-C were higher in the elderly than the middle-aged for men.
{"title":"Lipid Profile in the Elderly and Middle-Aged Patients with Type 2 Diabetes Mellitus in Relation with Gender","authors":"F. Saraç, S. Savaş, Bahattin Gökdemir, F. Akçiçek","doi":"10.25179/tjem.2019-66342","DOIUrl":"https://doi.org/10.25179/tjem.2019-66342","url":null,"abstract":"D O I: 10 .2 51 79 /t je m .2 01 966 34 2 Objective: The aim of the present study was to determine the lipid profile in the elderly and middle-aged patients with Type 2 diabetes mellitus (DM) and its relation with gender. Material and Methods: A total of 592 patients with Type 2 DM aged ≥60 years and 269 diabetic patients aged <60 years as middle-aged with initial admissions or patients with two months of antihyperlipidemic medicine pause were recruited from the internal medicine outpatient clinic during December 2012-March 2018. Demographic and biochemical data were collected retrospectively. Abnormal lipid levels were accepted as total-cholesterol >200 mg/dL, low density lipoprotein-cholesterol (LDL-C) ≥100 mg/dL, triglyceride (TG) ≥150 mg/dL, and high density lipoproteincholesterol (HDL-C) <50 in women <40 mg/dL in men. Results: In total, 506 (85.4%) elderly and 248 (92.1%) middle-aged patients had one or more types of dyslipidemia. There were statistically significant differences in the frequencies of isolated high TG (x2=7.54, p=0.01) and combined two parameter dyslipidemia such as LDL-C ≥100 mg/dL & HDL-C <40 mg/dL & TG <150 mg/dL (x2=4.30, p=0.03) for men between elderly and middle-aged patients. Combined two-parameter dyslipidemia such as LDL-C ≥100 mg/dL, TG ≥150 mg/dL & HDL-C >50 mg/dL (x2=6.64, p=0.01), and isolated low HDL-C (x2=2.91, p=0.05) for women were found to be different between the elderly and middle-aged patients. Conclusion: Hypertriglyceridemia with high LDL-C and isolated low HDL-C were more common in the elderly women than that in middle-aged women where isolated hypertriglyceridemia and combined high LDL-C with low HDL-C were higher in the elderly than the middle-aged for men.","PeriodicalId":425605,"journal":{"name":"The Turkish Journal of Endocrinology and Metabolism","volume":"34 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127608420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.25179/tjem.2021-82008
İ. H. Açar, N. Acar, Z. Sayiner, M. Araz, E. Akarsu
Objective: With the increase in the prevalence of diabetes and associated complications, most of the healthcare expenditure is due to treatments of diabetes complications. This study evaluated the determinants affecting the total treatment cost in hospitalized patients with diabetic foot ulcers (DFU), an important complication of diabetes. Material and Methods: Factors affecting cost in 300 cases of hospitalization due to DFU were analyzed retrospectively. Hospital invoices were examined, and incurred cost of each patient was calculated in Turkish lira and then converted into US dollars at the exchange rate on the date of hospitalization, considering the number of days of hospitalization. Results: Among the 300 included patients, the ratio of male/female participants was 1.94. The mean age of the patients was 62.6±11 years. Hemoglobin A1c mean was determined as 9.5±2.4%. The average hospitalization time was 17.8±12.9 days. When the average cost was analyzed according to Wagner phases, the average cost increased as the stage of the disease. The factor that most affected the cost was hospitalization cost (p=0.001, r=3.24). Diagnostic imaging tests affected the total cost the most (p=0.001, r=2.52) after hospitalization. Conclusion: The cost of hospitalization was the most important factor affecting the total cost in the analysis of DFU. Therefore, taking precautions before the advancement of ulcer stage and treatment at an early stage is expected to reduce the treatment cost. In addition, reducing the duration of hospital stay will be effective in reducing the cost of DFU treatment.
{"title":"Hospitalisation Cost of Diabetic Patients with Foot Ulcers: A Retrospective Descriptive Analysis from Turkey","authors":"İ. H. Açar, N. Acar, Z. Sayiner, M. Araz, E. Akarsu","doi":"10.25179/tjem.2021-82008","DOIUrl":"https://doi.org/10.25179/tjem.2021-82008","url":null,"abstract":"Objective: With the increase in the prevalence of diabetes and associated complications, most of the healthcare expenditure is due to treatments of diabetes complications. This study evaluated the determinants affecting the total treatment cost in hospitalized patients with diabetic foot ulcers (DFU), an important complication of diabetes. Material and Methods: Factors affecting cost in 300 cases of hospitalization due to DFU were analyzed retrospectively. Hospital invoices were examined, and incurred cost of each patient was calculated in Turkish lira and then converted into US dollars at the exchange rate on the date of hospitalization, considering the number of days of hospitalization. Results: Among the 300 included patients, the ratio of male/female participants was 1.94. The mean age of the patients was 62.6±11 years. Hemoglobin A1c mean was determined as 9.5±2.4%. The average hospitalization time was 17.8±12.9 days. When the average cost was analyzed according to Wagner phases, the average cost increased as the stage of the disease. The factor that most affected the cost was hospitalization cost (p=0.001, r=3.24). Diagnostic imaging tests affected the total cost the most (p=0.001, r=2.52) after hospitalization. Conclusion: The cost of hospitalization was the most important factor affecting the total cost in the analysis of DFU. Therefore, taking precautions before the advancement of ulcer stage and treatment at an early stage is expected to reduce the treatment cost. In addition, reducing the duration of hospital stay will be effective in reducing the cost of DFU treatment.","PeriodicalId":425605,"journal":{"name":"The Turkish Journal of Endocrinology and Metabolism","volume":"92 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128187048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：